We have characterized a new virulence factor in BordeteUla pertussis: serum resistance. Compared with Escherichia coli HB101, wild-type B. pertussis was relatively resistant to classical-pathway, complementdependent killing by normal human serum. However, a mutant of B. pertussis (BPM2041) which is less virulent in mice and which has Tn5 lac inserted in a previously uncharacterized bvg-regulated gene was found to be at least 10-fold more susceptible to serum killing than the wild type. We have named this locus brk, for Bordetella resistance to killing. We Bordetella pertussis is the causative agent of whooping cough. The virulence factors of this pathogenic microorganism are positively regulated by the bvgAS genetic locus (43, 44, 51) . Under specific environmental conditions, organisms with an intact bvg operon express the genes required for virulence and are virulent; organisms which do not express this virulence locus because of mutations in bvg are avirulent (53). In addition, certain growth conditions can reversibly suppress the expression of the virulence genes, a condition termed modulation (24, 29) . Genes known to be regulated by the bvg locus include the toxins, such as pertussis toxin, adenylate cyclase toxin, and dermonecrotic toxin; putative attachment factors, such as filamentous hemagglutinin (FHA), fimbriae, and pertactin; and other factors, such as capsule (50, 55) .
Bordetella pertussis is the causative agent of whooping cough. The virulence factors of this pathogenic microorganism are positively regulated by the bvgAS genetic locus (43, 44, 51) . Under specific environmental conditions, organisms with an intact bvg operon express the genes required for virulence and are virulent; organisms which do not express this virulence locus because of mutations in bvg are avirulent (53) . In addition, certain growth conditions can reversibly suppress the expression of the virulence genes, a condition termed modulation (24, 29) . Genes known to be regulated by the bvg locus include the toxins, such as pertussis toxin, adenylate cyclase toxin, and dermonecrotic toxin; putative attachment factors, such as filamentous hemagglutinin (FHA), fimbriae, and pertactin; and other factors, such as capsule (50, 55) .
In a previous study, we isolated mutants with mutations in bvg-regulated genes, using the transposon Tn5 lac (55) . This transposon possesses a promoterless 3-galactosidase (P-Gal) gene which is expressed only if the transposon inserts downstream from a functional promoter, and then p-Gal expression is regulated in the same manner as the intact gene. Several thousand TnS lac insertion mutants were screened, and those which expressed ,-Gal in a bvg-regulated manner were further characterized. Several of the mutants were deficient in known bvg-regulated genes, such as those encoding pertussis toxin, adenylate cyclase toxin, dermonecrotic toxin, and FHA. Other bvg-regulated mutants which were not deficient in expression of any of the previously described bvg-regulated factors were isolated. One such mutant, B. pertussis BPM2041, was further Reamstown, Pa.) as previously described (53) . E. coli HB101
and DH5o (Gibco/BRL, Gaithersburg, Md.) were grown on LB agar. When necessary, the following antibiotics at the indicated concentrations (in micrograms per milliliter) were added to the media: nalidixic acid, 30; kanamycin, 50; ampicillin, 100; gentamicin, 10; and streptomycin, 300. Plasmids were isolated by using either the midi-prep kit (Qiagen, Inc., Chatsworth, Calif.) or Magic/Wizard mini-prep kits (Promega Corporation, Madison, Wis.). Reagents. Restriction enzymes and T4 DNA ligase were purchased from Gibco/BRL or New England Biolabs (Beverly, Mass.) and used according to the manufacturer's specifications. SeaKem and SeaPlaque (low-melting-point) agarose were purchased from FMC BioProducts (Rockland, Maine). Antibiotics and 5-bromo-4-chloro-3-indolyl-,-D-galactopyranoside (X-Gal) were obtained from the Sigma Chemical Company (St. Louis, Mo.). Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) reagents were purchased from Bio-Rad Laboratories (Hercules, Calif.). Tissue culture media, antibiotic supplements, and fetal bovine serum were obtained from Whittaker Bioproducts (Walkersville, Md.). DNA and protein molecular weight markers were purchased from Gibco/BRL and Pharmacia (Piscataway, N.J.), respectively.
Mapping the brk locus. The brk locus was mapped by insertion duplication mutagenesis as described elsewhere (54, 55) . This procedure was also used to introduce a brkA4 mutation (see Fig. 3B Invasion assay. Confluent monolayers of MRC-5 cells grown in 24-well tissue culture plates were infected with BP338 or BPM2041 essentially as described above, with the radiolabeling step omitted. After a 3-h incubation, the inoculum was removed and the monolayers were washed extensively with PBS. The last wash was replaced with medium supplemented with 100 ,ug of gentamicin per ml and/or 100 jig of polymyxin B per ml. After a further 3-h incubation, the antibiotic was removed. The monolayers were subsequently washed twice with PBS, lysed with distilled water, and plated on BG medium to determine the number of antibiotic-resistant (i.e., invading) bacteria. The results from 10 independent experiments are reported.
Southern blot analysis. Chromosomal DNA was isolated by the CTAB (hexadecyltrimethyl ammonium bromide) method (2) . The DNA was digested with NotI, separated on a 0.8% agarose gel, and transferred to a positively charged nylon membrane (Boehringer Mannheim Corporation, Indianapolis, Ind.). The blot was probed with the 5' portion of the brk locus (see Fig. 3B , fragment a) which had been previously labeled with digoxigenin-dUTP by using the Genius kit (Boehringer). The blot was processed with anti-digoxigenin antibodies and LumiPhos 530 (Boehringer) and exposed to X-ray film.
SDS-PAGE analysis. B. pertussis strains were grown on BG medium for 24 h and harvested in SS broth to an optical density at 600 nm of 0.15. A 0.5-ml volume of this suspension was pelleted and resuspended in 50 ,ul of lysis buffer. The samples were boiled for 5 min and loaded on a discontinuous SDS-11% polyacrylamide gel (25) . Following electrophoresis, the separated proteins were visualized after being stained with Coomassie brilliant blue.
DNA sequencing and sequence analysis. Plasmids pRF1028 and pRF1029 were sequenced by Lark Sequencing Technologies, Inc. (Houston, Tex.). Sequence analysis was performed with the Genetics Computer Group package (9) and the electronic-mail servers BLAST (1) and GRAIL (47) . Transmembrane prediction analysis was done with the MEMSATPC program (22) , which was obtained by anonymous ftp from ftp.embl-heidelberg.de.
Nucleotide sequence accession number. The GenBank accession number is U12276.
RESULTS
The brk locus is associated with serum resistance. The results in Fig. 1 indicate that about 10% of the initial 107 wild-type B. pertussis organisms were able to survive for 60 min in pooled normal human serum. About 0.0001% of E. coli HB101 organisms survived similar treatment, suggesting that even at 10% survival, B. pertussis is relatively resistant to killing by human serum. The avirulent-phase (i.e., Vir-) mutant BP347 was killed more than 100 times more efficiently than the wild-type strain (P < 0.00002), implying that serum resistance is bvg regulated. The extent of survival of BPM2041 lies between those of the wild type and the Vir-strain, and the survival of BPM2041 is at least 10-fold more sensitive than that of the wild type (P < 0.00003).
The serum component mediating the killing of susceptible B. pertussis organisms appears to be complement: both heat inactivation and the pretreatment of serum with EDTA, which removes divalent cations required for complement activation, harboring insertions and duplications of the brk locus in the indicated fragments were tested for serum resistance. + and -, wild-type and mutant (BPM2041) levels of resistance, respectively. (C) Organization of the ORFs in the brk locus. cpn6O refers to the gene encoding the chaperonin or heat shock protein Hsp6O. result in the complete abrogation of serum killing (data not shown). To test which of the complement pathways (classical and/or alternate) was activated, organisms were exposed for 60 min to either 20% normal human serum or 20% normal human serum containing 10 mM EGTA and MgCl2. The latter treatment inactivates the classical pathway by chelating Ca2+ (21) . As indicated in Fig. 2 , unlike that of E. coli, which is killed by both the classical and the alternate pathways, serum killing of both wild-type and mutant strains of B. pertussis is completely abolished under conditions which inhibit the classical pathway. Thus, the Tn5 lac insertion in strain BPM2041 defines a locus which affords protection from killing by the classical pathway of complement. We have called this locus brk.
Cloning and mapping of the brk locus. A partial restriction map of the brk locus is presented in Fig. 3A . Chromosomal DNA from the TnS lac mutant strain BPM2041 was digested with NotI, and the DNA was cloned in pBluescriptll SK+. Transformants were screened on plates containing X-Gal and kanamycin. A single blue colony which expressed the 1-Gal and kanamycin resistance genes from Tn5 lac was picked and designated RF1001. Expression of 13-Gal in RF1001 was probably due to a fortuitous promoter. A 3.3-kb NotI-BamHI fragment representing the region 5' to the Tn5 lac insertion site and which included the BamHI site in TnS lac was subcloned to obtain pRF1003 (Fig. 3B, fragment a) . Determination of the orientation of this fragment defined the direction of transcription as left to right, since the transcriptional fusion with 1-Gal was used to identify this gene. pRF1003 was then used to probe a B. pertussis (BP338) cosmid library (49) , and two positive, overlapping clones were uncovered. One of these cosmids (pKWfl2) spanned the entire brk locus. From pKWfl2, a 3.7-kb NotI fragment representing the upstream portion of the brk locus was subcloned to render pRF1028. Similarly, an overlapping 3-kb EcoRI fragment representing the downstream section of the brk locus was subcloned to obtain pRF1029 (Fig. 3A) .
To map the start and the end of the brk locus, we employed insertion duplication mutagenesis (54) . In brief, a suicide plasmid containing a gentamicin cassette, an origin of transfer for P conjugation (3), and one of the fragments of the brk locus depicted in Fig. 3B was engineered. The plasmid was introduced into wild-type B. pertussis via triparental mating (54, 55) , and resistance to gentamicin was selected. Since the suicide plasmid cannot replicate in B. pertussis, all resulting gentamicin-resistant transconjugants are due to the insertion of the plasmid into the B. pertussis chromosome via homologous recombination. The chromosome thus contains two copies of the homologous region. In general, the results from insertion duplication mutagenesis can be interpreted as follows. If (41) . A single copy of the sequence TI"TCCT was found upstream of brkA, whereas two copies were found upstream of brkB. The TnS lac insertion site was mapped to position 3232 in brkA.
The database was searched for homologs of BrkA and BrkB by using BLAST (nonredundant protein database) and FASTA (SwissProt release 25) . The best match for BrkA was the Bordetella outer membrane protein pertactin (4) . BrkA is 100 amino acids larger than pertactin. With FASTA, BrkA was found to be 29% identical to pertactin in their 910 overlapping amino acids. The best match for BrkB was a 23.5% identity to 272 overlapping amino acids in the 290-amino-acid hypothetical E. coli protein ORF o290 identified by the E. coli genome project (37 Fig. 5 . The most striking identity is found in the C-terminal end. The two proteins are 54.5% identical over their last 300 amino acids and share a C terminal outer membrane localization motif (alternating hydrophobic residues in the last nine C-terminal amino acids ending with [preferentially] phenylalanine or tryptophan) (45) . Of particular note is the conservation of the pertactin proteolytic processing sites (10) in BrkA. In addition, each protein has two RGD (arginine-glycine-aspartic acid) sequences; the RGD pattern is associated with cell adhesion (42) . The spacing of the RGD's, however, is not conserved between the two proteins.
Whereas the positioning and alignment of the first RGD are fairly close between the two proteins, the positioning of the second RGD is not. In pertactin, the second RGD is found downstream of the processing site and appears to be absent from the mature protein (10 (27) . BrkA mutants of each strain were made by using construct d in Fig. 3B , and the resistance to serum killing was assessed. As shown in Fig. 6 , while the pertactin mutant is reduced in its ability to survive serum killing, this result is not significantly different from that for the parent strain (P < 0.13).
Disruption of the brkA gene in the parental BBC8 resulted in an approximately 20-fold reduction in serum resistance (P < 0.05), not unlike what is seen with BP338 BrkA mutants (Fig.   1 ). The pertactin-brkA4 double mutant also displayed a 20-fold reduction in serum killing compared with that of BBC9 (P < 0.02), thus belying a significant role for pertactin in serum resistance.
BrkB is predicted to be a cytoplasmic membrane protein.
An examination of the hydrophobicity profile of BrkB revealed the presence of six hydrophobic domains. This, coupled with the lack of a signal sequence and an outer membrane localization motif, suggested that BrkB may be a cytoplasmic membrane protein. This thesis was supported by the MEMSAT membrane prediction program (22) , which takes into account both structural and topological constraints (48 ysis, BrkB is strongly predicted to have six membrane-spanning (spanner) regions, with both the carboxy terminus and the amino terminus being found on the cytoplasmic side of the membrane (Fig. 7A ). In addition, potential sites for phosphorylation are present on the putative cytoplasmic side, with the predicted periplasmic side having sites for glycosaminoglycan attachment (12) and phosphorylation. Whether these sites are important for biological function is unknown. Although the best match from the database showed only 23.5% identity to BrkB, E. coli ORF o290 has a remarkably similar hydrophobicity plot. The next match in the database search (18.9% over 249 amino acids) was to an M. leprae 313-amino-acid ORF (GenBank no. U00022) recently identified by the M. leprae genome project. As with the E. coli o290 ORF, there was a striking similarity in the hydrophobicity profiles. In addition to the match with the aforementioned ORFs, domains of identity to the transmembrane regions of several different proteins (Fig. 7B ) which function to transport ions, electrons, and other small molecules were detected. The N-terminal half of the protein had a further match (Fig. 7B) to the heptad repeat, putative dimerization domain of the tumor suppressor adenamatous polyposis coli protein (11) . SDS-PAGE analysis. To visualize the presence of the Brk proteins, SDS-PAGE was performed. The Coomassie bluestained-protein profile for the wild-type strain was compared with profiles for BrkA and BrkB knockout mutants. We were looking for proteins present in the wild-type strain but absent in the respective mutants. As illustrated in Fig. 8 , there is an approximately 73-kDa protein present in both the wild-type strain (lane A) and the BrkB mutant (lane E). This size is not compatible with the predicted molecular mass of 103 kDa for BrkA but is consistent with the predicted molecular mass of the processed protein. The 73-kDa protein is noticeably absent in both brkA mutants (Fig. 8, lanes C and D) (Fig. 3B ). Means ± standard deviations are reported. n = 5 for BBC8 and BBC9; n = 3 for each of the BrkAstrains. DISCUSSION We have shown that serum resistance encoded by the brk locus is a newly described virulence factor for B. pertussis. Like other B. pertussis virulence factors, the brk locus is bvg regulated, with putative BvgA binding sites present upstream of both brkA and brkB (Fig. 4) . Most significantly, however, the original Brk mutant, BPM2041, is less virulent in infant mice (56) , thus underlining the importance of the brk locus in pathogenesis. It is reasonable to imagine that the ability to resist complement killing may be of consequence in B. pertussis infections in that it would serve to effectively enhance colonization. Although we cannot discount the possibility that resistance to serum killing may mimic other mucosal host defense systems, such as the defensin-like tracheal antimicrobial peptide (6), both antibody (23) and complement (35) (16, 17) , also have mechanisms to avoid complement killing or opsonization, respectively.
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We have cloned, mapped, and sequenced the Bordetella locus for resistance to killing (brk) and have shown that it has two highly predicted ORFs, termed BrkA and BrkB. Both are essential for serum resistance, since independent knockout mutations resulted in the loss of wild-type levels of resistance. A third ORF, which is not essential for serum resistance, is about 100 bases downstream of brkA and resembles the heat shock protein-chaperonin Cpn60. The juxtapositioning of heat shock genes and virulence genes has been demonstrated in Vibrio cholerae (33) . In V. cholerae, several virulence genes, including the tcpC gene, which is involved in serum resistance, are regulated by toxR (7, 34) . The toxR gene is adjacent to htpG, the gene encoding the heat shock protein Hsp9O. toxR and htpG are divergently transcribed, and their expression is modulated by temperature (33) . At 22°C, toxR is expressed, whereas at 37°C htpG is expressed. It was suggested that the competition between sigma-32 and sigma-70 RNA polymerases for the promoter site dictates which gene is expressed (33) The best match to BrkA in the database was found to be the Bordetella outer membrane protein pertactin. The two proteins were particularly similar over their last 300 amino acids. In fact, the proteolytic processing sites in pertactin, which produce N-terminal proteins of either 58.4 or 60.4 kDa (10) , are conserved in BrkA. If indeed BrkA is also processed at these sites, then the predicted molecular mass for BrkA would be about 73 kDa instead of 103 kDa. Our SDS-PAGE result which demonstrates an approximately 73-kDa protein present in the wild-type strain but absent in BrkA mutants supports this hypothesis.
Ligands bearing the RGD motif bind to integrin receptors on host cells (42) . Including BrkA, B. pertussis now has at least three virulence factors with RGD motifs. The first RGD, in pertactin, has been shown to bind to both HeLa and CHO cells (27) , and the RGD in FHA mediates attachment to the complement receptor CR3 on monocytes (40 (12) . N-term and C-term, N terminus and C terminus, respectively. (B) Line drawing of sequence comparisons of BrkB with other proteins in the database. The location of each match relative to BrkB is indicated by a line. The percent identity (FASTA) of each protein to BrkB is shown above the line; the amino acid numbers of the matched proteins are indicated below the line. E. coli o290 (37) The presence of the RGD motif in pertactin has been associated with invasion of CHO cells (26) . In comparison with wild-type B. pertussis, BrkA mutants are compromised by a factor of 2 in their ability to invade both HeLa (8) and MRC-5 cells, implying that BrkA also has some role in invasion and intracellular survival. Despite the similarities in sequence and in functions such as attachment and invasion, BrkA and pertactin differ in their abilities to confer serum resistance (Fig. 6) .
The second protein of the brk locus, BrkB, resembles proteins encoded by similar-size ORFs in E. coli (37) and M. leprae (GenBank no. U00022) both in the extent of amino acid identity and in their predicted hydropathy profiles. The functions of these ORFs have yet to be assigned. BrkB (Fig. 3B, fragment a) . Lanes A to F, B. pertussis (BP338), B. parapertussis (253), B. bronchiseptica (11DH), B. avium (wBA70), B. pertussis (BP347), and B. pertussis (BPM2041), respectively. DNA markers (in kilobases) are indicated on the left. protein (11) . Indeed, there is a perfect heptad repeat in the first transmembrane-spanning domain of BrkB. The presence of apolar amino acids in the first and fourth positions allows a' protein to adopt an a-helical coiled-coil structure (5) with another heptad repeat domain. Intramembrane helix interactions are not uncommon in integral membrane proteins (5) , and it is possible that in addition to the intramembrane interactions, BrkB may form a homodimer, thus conforming to the two-by-six structure (where six is the number of transmembrane spanners) which is a hallmark of many other transport proteins (15) .
Possible mechanisms of serum resistance can be offered on the basis of the predicted amino acid sequences of BrkA and BrkB. The outer membrane localization signal (45) on BrkA implies that it is targeted to the surface of B. pertussis. As a surface structure, it may act to sterically hinder or block the binding of lytic antibody to a bactericidal target, or it could elicit blocking antibody, which would perform a similar function (18) (19) (20) . Alternatively, the putative glycosaminoglycan attachment site on BrkA may influence serum resistance. The serum protein vitronectin has a heparin (glycosaminoglycan) binding site which acts to inhibit the polymerization of the complement component C9 (30, 38) . It is possible that BrkA could utilize its putative heparin binding site to hinder C9 polymerization. In this regard, inhibition of C9 polymerization is believed to be the mechanism by which the Rck protein mediates serum resistance in Salmonella typhimurium (13) .
We have proposed that BrkB is a cytoplasmic membrane protein. If so, how might a cytoplasmic membrane protein act to confer serum resistance? One possibility is that BrkB might aid in the secretion of BrkA. The outer membrane localization signal on BrkA predicts its targeting to the bacterial surface. BrkA, however, lacks an apparent signal sequence, suggesting that the conventional sec-mediated machinery (39) is not operative in this case. Thus, the serum sensitivity of the BrkB mutants may be explained by the failure of BrkA to be expressed on the surface, although BrkA does appear to be present in its processed form in BrkB mutants (Fig. 8) .
Alternatively, BrkB might serve to counteract the damage caused by complement attack. As argued by Taylor (46) , it is the damage to the cytoplasmic membrane and not necessarily the outer membrane which leads to the complement-mediated death of gram-negative bacteria. Perturbations of the cytoplasmic membrane resulting from complement attack can alter membrane potential, inhibit oxygen consumption, and cause a leakage of small molecules and ions (46) . It is tempting to speculate that the similarity of BrkB to other pumps may suggest that it acts as a transporter or channel that functions to maintain homeostasis following complement attack. Whether BrkB acts to transport BrkA or whether it acts as a transporter of small molecules is the focus of future studies.
Finally, since the brk locus also exists in B. parapertussis and B. bronchiseptica, and since possible homologs of BrkB have been detected in E. coli and M. leprae, it would be of interest to explore the role of brk in these organisms.
